These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16926135)

  • 21. Identification of an alternatively spliced form of the mouse AML1/RUNX1 gene transcript AML1c and its expression in early hematopoietic development.
    Fujita Y; Nishimura M; Taniwaki M; Abe T; Okuda T
    Biochem Biophys Res Commun; 2001 Mar; 281(5):1248-55. PubMed ID: 11243869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RUNX1/AML1: a central player in hematopoiesis.
    Okuda T; Nishimura M; Nakao M; Fujita Y
    Int J Hematol; 2001 Oct; 74(3):252-7. PubMed ID: 11721959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation.
    Aikawa Y; Nguyen LA; Isono K; Takakura N; Tagata Y; Schmitz ML; Koseki H; Kitabayashi I
    EMBO J; 2006 Sep; 25(17):3955-65. PubMed ID: 16917507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncogenic pathways of AML1-ETO in acute myeloid leukemia: multifaceted manipulation of marrow maturation.
    Elagib KE; Goldfarb AN
    Cancer Lett; 2007 Jun; 251(2):179-86. PubMed ID: 17125917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A germline point mutation in Runx1 uncouples its role in definitive hematopoiesis from differentiation.
    Dowdy CR; Frederick D; Zaidi SK; Colby JL; Lian JB; van Wijnen AJ; Gerstein RM; Stein JL; Stein GS
    Exp Hematol; 2013 Nov; 41(11):980-991.e1. PubMed ID: 23823022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Runx1/AML1 in normal and abnormal hematopoiesis.
    Yamagata T; Maki K; Mitani K
    Int J Hematol; 2005 Jul; 82(1):1-8. PubMed ID: 16105753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological characteristics of the leukemia-associated transcriptional factor AML1 disclosed by hematopoietic rescue of AML1-deficient embryonic stem cells by using a knock-in strategy.
    Okuda T; Takeda K; Fujita Y; Nishimura M; Yagyu S; Yoshida M; Akira S; Downing JR; Abe T
    Mol Cell Biol; 2000 Jan; 20(1):319-28. PubMed ID: 10594034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Runx1/AML-1 ranks as a master regulator of adult hematopoiesis.
    Ichikawa M; Asai T; Chiba S; Kurokawa M; Ogawa S
    Cell Cycle; 2004 Jun; 3(6):722-4. PubMed ID: 15213471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mouse RUNX1C regulates premegakaryocytic/erythroid output and maintains survival of megakaryocyte progenitors.
    Draper JE; Sroczynska P; Leong HS; Fadlullah MZH; Miller C; Kouskoff V; Lacaud G
    Blood; 2017 Jul; 130(3):271-284. PubMed ID: 28490570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of Runx1/AML1 and Evi-1 in the regulation of hematopoietic stem cells.
    Kumano K; Kurokawa M
    J Cell Physiol; 2010 Feb; 222(2):282-5. PubMed ID: 19847803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AML1/RUNX1 works as a negative regulator of c-Mpl in hematopoietic stem cells.
    Satoh Y; Matsumura I; Tanaka H; Ezoe S; Fukushima K; Tokunaga M; Yasumi M; Shibayama H; Mizuki M; Era T; Okuda T; Kanakura Y
    J Biol Chem; 2008 Oct; 283(44):30045-56. PubMed ID: 18687690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Src family kinase-Shp2 axis controls RUNX1 activity in megakaryocyte and T-lymphocyte differentiation.
    Huang H; Woo AJ; Waldon Z; Schindler Y; Moran TB; Zhu HH; Feng GS; Steen H; Cantor AB
    Genes Dev; 2012 Jul; 26(14):1587-601. PubMed ID: 22759635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The differential activities of Runx1 promoters define milestones during embryonic hematopoiesis.
    Sroczynska P; Lancrin C; Kouskoff V; Lacaud G
    Blood; 2009 Dec; 114(26):5279-89. PubMed ID: 19858498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The TEL-AML1 fusion protein of acute lymphoblastic leukemia modulates IRF3 activity during early B-cell differentiation.
    de Laurentiis A; Hiscott J; Alcalay M
    Oncogene; 2015 Dec; 34(49):6018-28. PubMed ID: 25893288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TEL-AML1 corrupts hematopoietic stem cells to persist in the bone marrow and initiate leukemia.
    Schindler JW; Van Buren D; Foudi A; Krejci O; Qin J; Orkin SH; Hock H
    Cell Stem Cell; 2009 Jul; 5(1):43-53. PubMed ID: 19570513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of AML/Runx and ETO/MTG family members during hematopoietic differentiation of embryonic stem cells.
    Okumura AJ; Peterson LF; Lo MC; Zhang DE
    Exp Hematol; 2007 Jun; 35(6):978-88. PubMed ID: 17533052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of RUNX1/AML1 during the G2/M transition.
    Wang S; Zhang Y; Soosairajah J; Kraft AS
    Leuk Res; 2007 Jun; 31(6):839-51. PubMed ID: 17023045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and characterization of a novel transcriptional target of RUNX1/AML1 at the onset of hematopoietic development.
    Ferreras C; Lancrin C; Lie-A-Ling M; Kouskoff V; Lacaud G
    Blood; 2011 Jul; 118(3):594-7. PubMed ID: 21498670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New mechanisms of AML1 gene alteration in hematological malignancies.
    Roumier C; Fenaux P; Lafage M; Imbert M; Eclache V; Preudhomme C
    Leukemia; 2003 Jan; 17(1):9-16. PubMed ID: 12529654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developmentally regulated promoter-switch transcriptionally controls Runx1 function during embryonic hematopoiesis.
    Pozner A; Lotem J; Xiao C; Goldenberg D; Brenner O; Negreanu V; Levanon D; Groner Y
    BMC Dev Biol; 2007 Jul; 7():84. PubMed ID: 17626615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.